For example, chemical modification with sodium metaperiodate followed by borohydride reduction was employed to destroy glycan-binding of recombinant β-glucuronidase (GUSB) used for treatment of mucopolysaccharidosis (MPS) VII (Grubb et al., 2008). Here, GUSB is linked to mucopolysaccharidosis type 7.